4
Changes in Ownership
AN2 Therapeutics, Inc. Filed Acc 0000899243-22-034294
Chief Executive Officer sold 9,350 shares at an average $15.76 ($147,358)
From the SEC's structured data for this filing
Trades in this filing
Easom Eric · Chief Executive Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-10-24 | Sale : show line 1 in the form | −2,866 | $16.17 | $46,344 | 11,391 | D |
| 2022-10-25 | Sale : show line 2 in the form | −4,272 | $15.69 | $67,020 | 7,119 | D |
| 2022-10-25 | Sale : show line 3 in the form | −534 | $16.20 | $8,652 | 6,585 | D |
| 2022-10-26 | Sale : show line 4 in the form | −1,678 | $15.10 | $25,342 | 4,907 | D |
| Open-market sales · 9,350 sh · avg $15.76 · $147,358 | ||||||
Loading xslF345X03/doc4.xml…